IFPMA

We have gathered global data that unveils the full scale and impact of the pharmaceutical industry on the health of patients, healthcare systems, and economies worldwide. 👉 Dive into our #AlwaysInnovating report: ifpma.info/3Cso7DQ

🌍 #KidneyDiseases affect millions and are linked to heart disease, diabetes, and hypertension, among others. On #WorldKidneyDay, we call for a more integrated approach to the prevention & management of #NCDs to reduce their global impact.

Antimicrobial resistance (#AMR) is a major global health threat, slowing progress in treatment & care reliant on effective #antibiotics. Our position paper outlines challenges in antibiotic #R&D and actions needed to revitalize innovation. 💡Read more👇 ifpma.info/4nwt2oF

30-40% of people with #NCDs, like CVD, diabetes, liver disease, kidney failure, and obesity, live with multiple conditions. On #WorldObesityDay, we call for stronger health innovation and integrated care for NCD prevention.👇 ifpma.info/4l6cnHo

💡 Medical breakthroughs don’t happen by chance–they rely on #innovation, investment, and collaboration. We’ve put together new data showing what it really takes to advance science and deliver tomorrow’s medicines and vaccines.👇 🔗 ifpma.info/3Cso7DQ #AlwaysInnovating

Congratulations to the Financing Accelerator Network on its first full year! Its innovative approach is advancing sustainable #NCD #healthfinancing in more and more LMICs. Excited to keep supporting this vital work!

Every year, 400k children develop cancer – 90% in LMICs. 🌍 On #InternationalChildhoodCancerDay, we’re highlighting the Global Platform for Access to Childhood Cancer Medicines to improve outcomes worldwide. 💡 ifpma.info/4rgA97i

Every year, an estimated 400,000 children develop #cancer. Nearly 90% of them live in LMICs, where survival rates remain low. 🌍 💡 Learn more about our partnerships to advance cancer care. 👇 ifpma.info/46BV0tu

As government leaders, international organizations & the private sector look at the future of #globalhealth, our Director General @DavidReddyIFPMA shares his perspective on what a meaningful reform could look like. 👉 Read more in the oped for @devex below

🌍 A warming planet and extreme weather events increase the threat from certain water and vector borne diseases. The innovative pharma industry is developing new medicines & vaccines that can address health effects linked to #ClimateChange 👇 ifpma.info/48ovJDa

👏 While notable progress has been made in the control & elimination of #NTDs 🌎, continued action is essential to sustain gains. Check out @GlobalHealthProgress to explore initiatives working to prevent, control & eliminate NTDs: globalhealthprogress.org

Happy New Year from IFPMA! Wishing you health, happiness, and inspiration in the year ahead. As we welcome this new year, we renew our commitment to advancing global health – for people, societies, and economies everywhere.  #AlwaysInnovating

💉Vaccines can reduce the burden of chronic diseases. In her article, Laetitia Bigger, Director of Vaccines Policy, explains how innovative vaccines can ease pressure on health systems and support healthier aging. 👉 ifpma.org/insights/the-p…

🌍 IFPMA is committed to progress toward Universal health Coverage (#UHC) & leverages innovation to achieve #HealthForAll, emphasizing: ➡️ Primary health care ➡️ Adequate financing ➡️ Multistakeholder partnerships. 👉bit.ly/4ip27tT

🤝As a founding member of @FightTheFakes, we work with partners to drive a long-term, sustainable, multi-pronged strategy to fight the serious threat of falsified medicines to global public health. ➡️ifpma.info/48uQ8rs

According to @UNAIDS, an estimated 40.8 million people are living with HIV globally. Working in partnership, the pharma industry is driving progress to #EndAIDS through advancing antiretroviral therapies & supporting better prevention, diagnosis, & care. ➡️bit.ly/4a5wGTj

📘 Through our Ethoscope, an IFPMA-led framework, we promote transparency, trust, and responsibility across the pharmaceutical industry. ifpma.info/47OgMKp

Promoting the highest standards of ethics and integrity is essential to advancing innovation and maintaining trust in healthcare.

There are over 230 vaccine candidates in the industry pipeline, with more than 30 influenza vaccines in active clinical trials. Read more at 👇 ifpma.info/3LXfKEF

😷Influenza is most serious for older people, pregnant women, young children, and people with underlying health conditions. ➡️The innovative pharmaceutical industry works to improve seasonal influenza vaccine coverage and wider influenza pandemic preparedness for the future.

💊Antimicrobial resistance (#AMR) threatens modern medicine, making infections harder to treat. The innovative pharmaceutical industry is calling for urgent action, including prioritizing and strengthening pull incentives for antibiotic R&D. 📎ifpma.info/4nGqmFd